Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts. more
Time Frame | IRON | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.28% | -3.13% | -0.02% |
1-Month Return | -0.96% | -4.8% | 1.48% |
3-Month Return | 35.94% | -8.46% | 9.63% |
6-Month Return | 68.49% | -2.88% | 13.17% |
1-Year Return | 8.01% | 6.92% | 31.56% |
3-Year Return | -70.81% | 4.63% | 30.19% |
5-Year Return | -92.89% | 42.11% | 93.4% |
Dec '20 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | 322.00K | 192.00K | 300.00K | 100.00K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":59.63,"profit":true},{"date":"2022-12-31","value":93.17,"profit":true},{"date":"2023-12-31","value":31.06,"profit":true}] | |
Gross Profit | (322.00K) | (192.00K) | (300.00K) | (100.00K) | [{"date":"2020-12-31","value":-32200000,"profit":false},{"date":"2021-12-31","value":-19200000,"profit":false},{"date":"2022-12-31","value":-30000000,"profit":false},{"date":"2023-12-31","value":-10000000,"profit":false}] | |
Gross Margin | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Operating Expenses | 34.04M | 30.93M | 47.48M | 91.13M | [{"date":"2020-12-31","value":37.36,"profit":true},{"date":"2021-12-31","value":33.95,"profit":true},{"date":"2022-12-31","value":52.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Operating Income | (34.04M) | (30.93M) | (47.48M) | (91.13M) | [{"date":"2020-12-31","value":-3404000000,"profit":false},{"date":"2021-12-31","value":-3093300000,"profit":false},{"date":"2022-12-31","value":-4747500000,"profit":false},{"date":"2023-12-31","value":-9112500000,"profit":false}] | |
Total Non-Operating Income/Expense | (13.59M) | (7.18M) | 1.36M | 25.30M | [{"date":"2020-12-31","value":-53.69,"profit":false},{"date":"2021-12-31","value":-28.37,"profit":false},{"date":"2022-12-31","value":5.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Pre-Tax Income | (40.84M) | (35.97M) | (46.83M) | (76.33M) | [{"date":"2020-12-31","value":-4083700000,"profit":false},{"date":"2021-12-31","value":-3596900000,"profit":false},{"date":"2022-12-31","value":-4682700000,"profit":false},{"date":"2023-12-31","value":-7633000000,"profit":false}] | |
Income Taxes | 6.83M | 5.04M | (737.00K) | 99.00K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":73.78,"profit":true},{"date":"2022-12-31","value":-10.8,"profit":false},{"date":"2023-12-31","value":1.45,"profit":true}] | |
Income After Taxes | (47.66M) | (41.01M) | (46.09M) | (76.43M) | [{"date":"2020-12-31","value":-4766300000,"profit":false},{"date":"2021-12-31","value":-4100500000,"profit":false},{"date":"2022-12-31","value":-4609000000,"profit":false},{"date":"2023-12-31","value":-7642900000,"profit":false}] | |
Income From Continuous Operations | (40.84M) | (71.87M) | (46.83M) | (64.09M) | [{"date":"2020-12-31","value":-4083700000,"profit":false},{"date":"2021-12-31","value":-7186900000,"profit":false},{"date":"2022-12-31","value":-4682700000,"profit":false},{"date":"2023-12-31","value":-6409400000,"profit":false}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (47.66M) | (41.01M) | (46.09M) | (76.43M) | [{"date":"2020-12-31","value":-4766300000,"profit":false},{"date":"2021-12-31","value":-4100500000,"profit":false},{"date":"2022-12-31","value":-4609000000,"profit":false},{"date":"2023-12-31","value":-7642900000,"profit":false}] | |
EPS (Diluted) | (2.07) | (18.10) | (6.40) | (3.42) | [{"date":"2020-12-31","value":-207,"profit":false},{"date":"2021-12-31","value":-1810,"profit":false},{"date":"2022-12-31","value":-640,"profit":false},{"date":"2023-12-31","value":-342,"profit":false}] | |
These ratios help you determine the liquidity of the company. Higher is better.
IRON | |
---|---|
Cash Ratio | 19.13 |
Current Ratio | 19.36 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IRON | |
---|---|
ROA (LTM) | -17.91% |
ROE (LTM) | -25.03% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IRON | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.05 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.95 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IRON | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 4.29 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Disc Medicine Inc. (IRON) share price today is $63.865
Yes, Indians can buy shares of Disc Medicine Inc. (IRON) on Vested. To buy Disc Medicine Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IRON stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Disc Medicine Inc. (IRON) via the Vested app. You can start investing in Disc Medicine Inc. (IRON) with a minimum investment of $1.
You can invest in shares of Disc Medicine Inc. (IRON) via Vested in three simple steps:
The 52-week high price of Disc Medicine Inc. (IRON) is $77.6. The 52-week low price of Disc Medicine Inc. (IRON) is $25.6.
The price-to-earnings (P/E) ratio of Disc Medicine Inc. (IRON) is
The price-to-book (P/B) ratio of Disc Medicine Inc. (IRON) is 4.29
The dividend yield of Disc Medicine Inc. (IRON) is 0.00%
The market capitalization of Disc Medicine Inc. (IRON) is $2.01B
The stock symbol (or ticker) of Disc Medicine Inc. is IRON